Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of the Safety and Efficacy of Iron Reduction by Phlebotomy in Recipients of Hematopoietic Stem Cell Transplants

NCT00689182 is registered in ClinicalTrials.gov with Andrea Kew as lead sponsor.

NCT NCT00689182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00689182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of the Safety and Efficacy of Iron Reduction by Phlebotomy in Recipients of Hematopoietic Stem Cell Transplants
Lead sponsor
Andrea Kew
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2007
Completion date
December 31, 2012
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron overload